Literature DB >> 22500017

Lecithin:cholesterol acyltransferase deficiency protects against cholesterol-induced hepatic endoplasmic reticulum stress in mice.

Lauren Hager1, Lixin Li, Henry Pun, Lu Liu, Mohammad A Hossain, Graham F Maguire, Mark Naples, Chris Baker, Lilia Magomedova, Jonathan Tam, Khosrow Adeli, Carolyn L Cummins, Philip W Connelly, Dominic S Ng.   

Abstract

We recently reported that lecithin:cholesterol acyltransferase (LCAT) knock-out mice, particularly in the LDL receptor knock-out background, are hypersensitive to insulin and resistant to high fat diet-induced insulin resistance (IR) and obesity. We demonstrated that chow-fed Ldlr-/-xLcat+/+ mice have elevated hepatic endoplasmic reticulum (ER) stress, which promotes IR, compared with wild-type controls, and this effect is normalized in Ldlr-/-xLcat-/- mice. In the present study, we tested the hypothesis that hepatic ER cholesterol metabolism differentially regulates ER stress using these models. We observed that the Ldlr-/-xLcat+/+ mice accumulate excess hepatic total and ER cholesterol primarily attributed to increased reuptake of biliary cholesterol as we observed reduced biliary cholesterol in conjunction with decreased hepatic Abcg5/g8 mRNA, increased Npc1l1 mRNA, and decreased Hmgr mRNA and nuclear SREBP2 protein. Intestinal NPC1L1 protein was induced. Expression of these genes was reversed in the Ldlr-/-xLcat-/- mice, accounting for the normalization of total and ER cholesterol and ER stress. Upon feeding a 2% high cholesterol diet (HCD), Ldlr-/-xLcat-/- mice accumulated a similar amount of total hepatic cholesterol compared with the Ldlr-/-xLcat+/+ mice, but the hepatic ER cholesterol levels remained low in conjunction with being protected from HCD-induced ER stress and IR. Hepatic ER stress correlates strongly with hepatic ER free cholesterol but poorly with hepatic tissue free cholesterol. The unexpectedly low ER cholesterol seen in HCD-fed Ldlr-/-xLcat-/- mice was attributable to a coordinated marked up-regulation of ACAT2 and suppressed SREBP2 processing. Thus, factors influencing the accumulation of ER cholesterol may be important for the development of hepatic insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22500017      PMCID: PMC3370258          DOI: 10.1074/jbc.M112.340919

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Opposing Gatekeepers of Apical Sterol Transport: Niemann-Pick C1-Like 1 (NPC1L1) and ATP-Binding Cassette Transporters G5 and G8 (ABCG5/ABCG8).

Authors:  J Mark Brown; Liqing Yu
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2009-03

2.  Sarco(endo)plasmic reticulum Ca2+-ATPase 2b is a major regulator of endoplasmic reticulum stress and glucose homeostasis in obesity.

Authors:  Sang Won Park; Yingjiang Zhou; Jaemin Lee; Justin Lee; Umut Ozcan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

Review 3.  Pathogenesis of cholesterol and pigment gallstones: an update.

Authors:  Karel Johannes Van Erpecum
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-02-25       Impact factor: 2.947

4.  Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes.

Authors:  Umut Ozcan; Erkan Yilmaz; Lale Ozcan; Masato Furuhashi; Eric Vaillancourt; Ross O Smith; Cem Z Görgün; Gökhan S Hotamisligil
Journal:  Science       Date:  2006-08-25       Impact factor: 47.728

5.  NPC2 regulates biliary cholesterol secretion via stimulation of ABCG5/G8-mediated cholesterol transport.

Authors:  Yoshihide Yamanashi; Tappei Takada; Takashi Yoshikado; Jun-Ichi Shoda; Hiroshi Suzuki
Journal:  Gastroenterology       Date:  2011-03-21       Impact factor: 22.682

6.  Novel function of Niemann-Pick C1-like 1 as a negative regulator of Niemann-Pick C2 protein.

Authors:  Yoshihide Yamanashi; Tappei Takada; Jun-Ichi Shoda; Hiroshi Suzuki
Journal:  Hepatology       Date:  2012-01-30       Impact factor: 17.425

7.  Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.

Authors:  Ryan E Temel; Weiqing Tang; Yinyan Ma; Lawrence L Rudel; Mark C Willingham; Yiannis A Ioannou; Joanna P Davies; Lisa-Mari Nilsson; Liqing Yu
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

Review 8.  Restoring endoplasmic reticulum function by chemical chaperones: an emerging therapeutic approach for metabolic diseases.

Authors:  F Engin; G S Hotamisligil
Journal:  Diabetes Obes Metab       Date:  2010-10       Impact factor: 6.577

Review 9.  Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease.

Authors:  Xavier Rousset; Boris Vaisman; Marcelo Amar; Amar A Sethi; Alan T Remaley
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-04       Impact factor: 3.243

10.  Localization of ABCG5 and ABCG8 proteins in human liver, gall bladder and intestine.

Authors:  Eric L Klett; Mi-Hye Lee; David B Adams; Kenneth D Chavin; Shailendra B Patel
Journal:  BMC Gastroenterol       Date:  2004-09-21       Impact factor: 3.067

View more
  19 in total

1.  Lipid droplets, potential biomarker and metabolic target in glioblastoma.

Authors:  Feng Geng; Deliang Guo
Journal:  Intern Med Rev (Wash D C)       Date:  2017-05

2.  The incretin enhancer, sitagliptin, exacerbates expression of hepatic inflammatory markers in rats fed a high-cholesterol diet.

Authors:  Rashmi Pathak; Avinash Kumar; Henry A Palfrey; Laura A Forney; Kirsten P Stone; Narayan R Raju; Thomas W Gettys; Subramanyam N Murthy
Journal:  Inflamm Res       Date:  2019-05-09       Impact factor: 4.575

Review 3.  Dynamics of hepatic and intestinal cholesterol and bile acid pathways: The impact of the animal model of estrogen deficiency and exercise training.

Authors:  Jean-Marc Lavoie
Journal:  World J Hepatol       Date:  2016-08-18

Review 4.  Translational approaches: from fatty liver to non-alcoholic steatohepatitis.

Authors:  Natalia Rosso; Norberto C Chavez-Tapia; Claudio Tiribelli; Stefano Bellentani
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

5.  GRP78 rescues the ABCG5 ABCG8 sterol transporter in db/db mice.

Authors:  Yuhuan Wang; Kai Su; Nadezhda S Sabeva; Ailing Ji; Deneys R van der Westhuyzen; Fabienne Foufelle; Xia Gao; Gregory A Graf
Journal:  Metabolism       Date:  2015-08-15       Impact factor: 8.694

6.  Lecithin:Cholesterol Acyltransferase (LCAT) Deficiency Promotes Differentiation of Satellite Cells to Brown Adipocytes in a Cholesterol-dependent Manner.

Authors:  Dinushan Nesan; Ghazaleh Tavallaee; Deborah Koh; Amir Bashiri; Rawand Abdin; Dominic S Ng
Journal:  J Biol Chem       Date:  2015-10-22       Impact factor: 5.157

7.  Obesity and endoplasmic reticulum (ER) stresses.

Authors:  Yamini B Tripathi; Vivek Pandey
Journal:  Front Immunol       Date:  2012-08-07       Impact factor: 7.561

Review 8.  Treatment of nonalcoholic steatohepatitis in adults: present and future.

Authors:  S Gitto; G Vitale; E Villa; P Andreone
Journal:  Gastroenterol Res Pract       Date:  2015-03-18       Impact factor: 2.260

9.  Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway.

Authors:  Zu-Guo Zheng; Si-Tong Zhu; Hui-Min Cheng; Xin Zhang; Gang Cheng; Pyone Myat Thu; Supeng Perry Wang; Hui-Jun Li; Ming Ding; Lei Qiang; Xiao-Wei Chen; Qing Zhong; Ping Li; Xiaojun Xu
Journal:  Autophagy       Date:  2020-05-20       Impact factor: 16.016

10.  High dietary cholesterol and ovariectomy in rats repress gene expression of key markers of VLDL and bile acid metabolism in liver.

Authors:  Zahra Farahnak; Isabelle Côté; Emilienne T Ngo Sock; Jean-Marc Lavoie
Journal:  Lipids Health Dis       Date:  2015-10-09       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.